Tokyo Tape
Sign in
← Hokuyaku Takeyama Holdings

Quarterly report · Q3

3055.TEDINET S100Q3RS
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥198.6bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥248.4bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥188.6bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥2.2bn2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥1.7bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥3.2bn2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥3.4bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.7bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥3.6bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥3.0bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥2.4bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.8bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.1bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥2.4bn2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥2.1bn2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥146.6bnat 2022-12-31Cons.Assets
Total assets¥136.9bnat 2022-03-31Cons.Assets
Total assets¥142.2bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥89.0bnat 2022-12-31Cons.Liabilities
Total liabilities¥81.3bnat 2022-03-31Cons.Liabilities
Net assets / equity¥57.6bnat 2022-12-31Cons.Net assets
Net assets / equity¥55.5bnat 2022-03-31Cons.Net assets
Net assets / equity¥55.5bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥21.4bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥21.1bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥21.4bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥21.1bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥20.7bnat 2021-12-31Cons.Cash and cash equivalents
Cash & equivalents¥20.4bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥2.0bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥3.2bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.6bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥856m2022-04-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.7bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥491m2021-04-01 → 2021-12-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥808m2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥849m2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥824m2021-04-01 → 2021-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥109.942022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥46.722022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥123.442021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥90.42021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥38.442021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio39.3%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio40.6%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio39.1%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 56
SegmentItemPeriodValue
Otherother segmentsrevenue2022-04-01 → 2022-12-31¥1.9bn
Otherother segmentsrevenue external2022-04-01 → 2022-12-31¥46m
Otherother segmentsrevenue intersegment2022-04-01 → 2022-12-31¥1.8bn
Otherother segmentssegment profit2022-04-01 → 2022-12-31¥819m
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentrevenue2022-04-01 → 2022-12-31¥10.2bn
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentrevenue external2022-04-01 → 2022-12-31¥10.2bn
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥9m
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentsegment profit2022-04-01 → 2022-12-31−¥14m
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentrevenue2022-04-01 → 2022-12-31¥1.2bn
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentrevenue external2022-04-01 → 2022-12-31¥362m
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥825m
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentsegment profit2022-04-01 → 2022-12-31¥25m
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue2022-04-01 → 2022-12-31¥49.2bn
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue external2022-04-01 → 2022-12-31¥48.9bn
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥379m
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.1bn
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentrevenue2022-04-01 → 2022-12-31¥3.0bn
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentrevenue external2022-04-01 → 2022-12-31¥3.0bn
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥2m
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentsegment profit2022-04-01 → 2022-12-31¥295m
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue2022-04-01 → 2022-12-31¥143.0bn
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue external2022-04-01 → 2022-12-31¥136.1bn
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥6.9bn
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥208.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥198.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥9.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥3.3bn
Otherother segmentsrevenue2021-04-01 → 2021-12-31¥1.3bn
Otherother segmentsrevenue external2021-04-01 → 2021-12-31¥45m
Otherother segmentsrevenue intersegment2021-04-01 → 2021-12-31¥1.2bn
Otherother segmentssegment profit2021-04-01 → 2021-12-31¥264m
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentrevenue2021-04-01 → 2021-12-31¥10.3bn
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentrevenue external2021-04-01 → 2021-12-31¥10.3bn
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥10m
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentsegment profit2021-04-01 → 2021-12-31¥122m
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentrevenue2021-04-01 → 2021-12-31¥1.0bn
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentrevenue external2021-04-01 → 2021-12-31¥331m
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥700m
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentsegment profit2021-04-01 → 2021-12-31¥60m
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue2021-04-01 → 2021-12-31¥47.2bn
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue external2021-04-01 → 2021-12-31¥46.9bn
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥350m
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentsegment profit2021-04-01 → 2021-12-31¥875m
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentrevenue2021-04-01 → 2021-12-31¥2.9bn
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentrevenue external2021-04-01 → 2021-12-31¥2.8bn
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥6m
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentsegment profit2021-04-01 → 2021-12-31¥272m
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue2021-04-01 → 2021-12-31¥135.0bn
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue external2021-04-01 → 2021-12-31¥128.2bn
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥6.8bn
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentsegment profit2021-04-01 → 2021-12-31¥577m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥197.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥188.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-12-31¥9.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥2.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 514
ItemContextValueUnit
Noncurrent liabilitiesPrior1YearInstant3125000000JPY
Noncurrent liabilitiesCurrentQuarterInstant3184000000JPY
LiabilitiesPrior1YearInstant81340000000JPY
LiabilitiesCurrentQuarterInstant89023000000JPY
Capital stockPrior1YearInstant1000000000JPY
Capital stockCurrentQuarterInstant1000000000JPY
Capital surplusPrior1YearInstant11821000000JPY
Capital surplusCurrentQuarterInstant11821000000JPY
Retained earningsPrior1YearInstant38965000000JPY
Retained earningsCurrentQuarterInstant41022000000JPY
Treasury stockPrior1YearInstant-1325000000JPY
Treasury stockCurrentQuarterInstant-1709000000JPY
Shareholders equityPrior1YearInstant50461000000JPY
Shareholders equityCurrentQuarterInstant52135000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant5909000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant6238000000JPY
Revaluation reserve for landPrior1YearInstant-742000000JPY
Revaluation reserve for landCurrentQuarterInstant-742000000JPY
Remeasurements of defined benefit plansPrior1YearInstant-96000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-81000000JPY
Valuation and translation adjustmentsPrior1YearInstant5070000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant5414000000JPY
Non controlling interestsPrior1YearInstant11000000JPY
Non controlling interestsCurrentQuarterInstant12000000JPY
Net assetsPrior1YearInstant55543000000JPY
Net assetsCurrentQuarterInstant57562000000JPY
Liabilities and net assetsPrior1YearInstant136883000000JPY
Liabilities and net assetsCurrentQuarterInstant146585000000JPY
Net salesPrior1YTDDuration188576000000JPY
Net salesCurrentYTDDuration198607000000JPY
Cost of salesPrior1YTDDuration174390000000JPY
Cost of salesCurrentYTDDuration183633000000JPY
Gross profitPrior1YTDDuration14186000000JPY
Gross profitCurrentYTDDuration14974000000JPY
Packing expenses sgaPrior1YTDDuration807000000JPY
Packing expenses sgaCurrentYTDDuration806000000JPY
Salaries sgaPrior1YTDDuration6411000000JPY
Salaries sgaCurrentYTDDuration6597000000JPY
Provision for bonuses sgaPrior1YTDDuration486000000JPY
Provision for bonuses sgaCurrentYTDDuration516000000JPY
Provision for directors bonuses sgaPrior1YTDDuration85000000JPY
Provision for directors bonuses sgaCurrentYTDDuration83000000JPY
Retirement benefit expenses sgaPrior1YTDDuration264000000JPY
Retirement benefit expenses sgaCurrentYTDDuration276000000JPY
Legal and employee benefits expenses sgaPrior1YTDDuration1162000000JPY
Legal and employee benefits expenses sgaCurrentYTDDuration1170000000JPY
Rent expenses sgaPrior1YTDDuration214000000JPY
Rent expenses sgaCurrentYTDDuration218000000JPY
Other sgaPrior1YTDDuration3071000000JPY
Other sgaCurrentYTDDuration3082000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass